NCT01661283 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01661283
Title	Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Sarcoma Alliance for Research through Collaboration
Indications	peripheral nerve sheath neoplasm
Therapies	Bevacizumab + Everolimus
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 12 of 12 entries

Facility	City	State	Zip	Country	Details
Ann and Robert Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	United States	Details
Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	United States	Details
Children's National Medical Center	Washington	District of Columbia	20010	United States	Details
Cincinnati Children's Hospital Medical Center	Cincinnati	Ohio	45229-3039	United States	Details
Johns Hopkins	Baltimore	Maryland	21218	United States	Details
Massachusetts General Hospital	Boston	Massachusetts	02114	United States	Details
National Cancer Institute	Bethesda	Maryland	20892-1101	United States	Details
Pennsylvania Oncology Hematology Associates	Philadelphia	Pennsylvania	19106	United States	Details
University of Alabama at Birmingham	Birmingham	Alabama	35294-0024	United States	Details
University of Iowa	Iowa City	Iowa	52242	United States	Details
University of Michigan	Ann Arbor	Michigan	48109	United States	Details
Washington University in St. Louis	Saint Louis	Missouri	63130	United States	Details

Showing 1 to 12 of 12 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01661283Clinical Trial Detail